TIMM8A Human

Translocase of Inner Mitochondrial Membrane 8 Homolog A Human Recombinant
Shipped with Ice Packs
In Stock

Description

Gene Overview

TIMM8A (Translocase of Inner Mitochondrial Membrane 8 Homolog A) is an X-linked gene (Xq22) encoding a mitochondrial intermembrane space chaperone critical for protein import and mitochondrial function . It is a member of the small TIM protein family, forming a heterohexameric complex with TIMM13 to facilitate the transport of hydrophobic proteins across the mitochondrial intermembrane space .

Molecular Structure

  • Gene Span: 3,313 base pairs, producing an 11 kDa protein (97 amino acids) .

  • Domains: Contains twin CX₃C zinc-binding motifs critical for structural stability and substrate interactions .

  • Paralogs: TIMM8B shares 49% sequence identity but exhibits tissue-specific expression divergence (e.g., TIMM8A is enriched in neuronal and hepatic tissues) .

Functional Role in Mitochondrial Biology

TIMM8A functions as a chaperone in two key processes:

  1. Protein Transport: Mediates the transfer of β-barrel precursors from the TOM complex to the SAM complex for outer membrane assembly .

  2. Inner Membrane Biogenesis: Escorts multi-pass transmembrane proteins (e.g., TIMM23, SLC25A12/ARALAR1) to the inner membrane .

Key Interactions:

Protein/ComplexRoleReference
TIMM13Forms a 70 kDa heterohexamer for substrate shielding
COX17Transiently interacts during Complex IV assembly
TIM22 ComplexAssists in metabolite carrier insertion

Genetic Disorders

Mohr-Tranebjærg Syndrome (MTS/DDON Syndrome)

  • Cause: Loss-of-function mutations (nonsense, frameshift, or deletions) in TIMM8A .

  • Symptoms:

    • Progressive sensorineural deafness (onset: childhood)

    • Dystonia, optic atrophy, cognitive decline .

  • Notable Mutations:

    MutationClinical ImpactReference
    c.233C>G (C66W)Disrupts zinc-binding, destabilizes complex
    108delGTruncates protein, abolishes function
    Exon 2 DeletionLoss of TIMM8A and partial BTK (causes combined XLA + DDON)

Cancer Associations

Breast Cancer Prognosis:

  • Expression: Upregulated in tumor tissues (AUC = 0.679, ROC analysis) .

  • Survival Impact: High TIMM8A correlates with poor prognosis (HR = 1.83, P < 0.001; median OS: 115.4 vs. 148.5 months) .

  • Immune Checkpoints: Positively correlates with PD-L1 and CTLA-4 expression, suggesting immune evasion roles .

Mitochondrial Dysfunction

  • Complex IV Defects: TIMM8A depletion reduces cytochrome c oxidase activity, leading to oxidative stress and apoptosis susceptibility .

  • Therapeutic Rescue: Vitamin E alleviates oxidative stress, restoring cell viability in neuronal models .

Diagnostic and Therapeutic Implications

  • Biomarker Potential: TIMM8A methylation at seven CpG sites predicts breast cancer survival .

  • Drug Candidates: Cyclosporine, tretinoin, and leflunomide identified as potential inhibitors via CTD database .

Research Gaps and Future Directions

  1. Neuronal Specificity: Why TIMM8A mutations predominantly affect neuronal cells despite ubiquitous mitochondrial roles .

  2. Paralog Redundancy: Functional overlap between TIMM8A and TIMM8B remains undefined .

  3. Therapeutic Targets: Antioxidants (e.g., Vitamin E) require clinical validation for MTS .

Product Specs

Introduction
Translocase of Inner Mitochondrial Membrane 8 Homolog A (TIMM8A) is involved in the import and insertion of hydrophobic membrane proteins from the cytoplasm into the mitochondria. This protein acts as a chaperone-like protein, safeguarding hydrophobic precursors from aggregation and guiding them through the mitochondrial intermembrane space. TIMM8A is crucial for transferring beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Defects in TIMM8A are linked to Jensen syndrome. TIMM8A and TIMM13 together form a 70 kDa heterohexamer.
Description
Recombinant human TIMM8A, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 120 amino acids (residues 1-97). It has a molecular weight of 13.4 kDa. This protein is fused to a 23 amino acid His-Tag at its N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The TIMM8A solution is provided at a concentration of 0.25 mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 0.15M NaCl, 30% glycerol, and 1mM DTT.
Stability
For short-term storage (up to 2-4 weeks), the solution should be stored at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of TIMM8A is greater than 90.0% as determined by SDS-PAGE analysis.
Synonyms
Mitochondrial import inner membrane translocase subunit Tim8 A, TIMM8A, Translocase of Inner Mitochondrial Membrane 8 Homolog A, DDP, DDP1, DFN1, MTS, TIM8, Deafness dystonia protein 1, X-linked deafness dystonia protein.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMDSSSSS SAAGLGAVDP QLQHFIEVET QKQRFQQLVH QMTELCWEKC MDKPGPKLDS RAEACFVNCV ERFIDTSQFI LNRLEQTQKS KPVFSESLSD.

Q&A

What is the TIMM8A gene and what is its role in mitochondrial function?

TIMM8A encodes hTim8a, one of six small TIM proteins in human mitochondria. Unlike its yeast counterpart, human Tim8a doesn't primarily function in the import of Tim23 as previously assumed. Instead, it serves as an auxiliary assembly factor for respiratory chain Complex IV (cytochrome c oxidase) .

Methodologically, researchers can study TIMM8A using BN-PAGE (Blue Native Polyacrylamide Gel Electrophoresis) to analyze protein complexes, co-immunoprecipitation to identify interaction partners, and functional assays to measure Complex IV activity. Knockout studies in different cell types have been instrumental in revealing cell-specific functions of hTim8a .

How do TIMM8A mutations lead to Mohr-Tranebjærg syndrome?

Mohr-Tranebjærg syndrome (MTS) is an X-linked recessive neurodegenerative disorder characterized by progressive sensorineural hearing loss, dystonia, cortical blindness, and dysphagia . The pathomechanism involves Complex IV assembly defects leading to oxidative stress and sensitization of neuronal cells to apoptosis .

Research approaches include:

  • CRISPR/Cas9 gene editing to create cellular models of MTS

  • Measurement of Complex IV activity in patient samples or model systems

  • Assessment of reactive oxygen species (ROS) levels and oxidative damage

  • Analysis of mitochondrial membrane potential and apoptotic markers

Notably, Vitamin E treatment has been shown to rescue cells from apoptotic vulnerability by alleviating oxidative stress, suggesting potential therapeutic strategies .

What are the differences between hTim8a and its paralog hTim8b?

hTim8a and hTim8b are paralogues that arose through gene duplication during chordate evolution. They share 49% sequence identity, with most divergence in the putative substrate binding regions at both the N- and C-termini .

Key differences include:

  • Tissue-specific expression: hTim8a is predominantly expressed in brain and liver (particularly fetal brain), while hTim8b shows broader expression, most prominently in endocrine and skeletal muscle tissue

  • Cell-specific function: hTim8a function is more prominent in neuronal-like SH-SY5Y cells, while hTim8b function is more prominent in HEK293 cells

  • Disease association: Only TIMM8A mutations are associated with a neurodegenerative disorder (MTS)

Both proteins form heterohexamers with hTim13 but do not interact together as a hTim8a-hTim8b heterohexamer in vitro .

How can researchers effectively study Complex IV assembly defects resulting from TIMM8A mutations?

Complex IV assembly defects can be investigated through multiple complementary approaches:

  • BN-PAGE analysis of mitochondrial extracts to visualize assembled and intermediate complexes

  • Measurement of Complex IV activity using spectrophotometric assays

  • Oxygen consumption analysis using respirometry techniques

  • Proteomic analysis of Complex IV subunits and assembly factors

  • In vitro import assays to assess the assembly of radioactively labeled Complex IV subunits

Research has shown that loss of hTim8a leads to reduced levels of key Complex IV assembly factors, including COX17 and COA4, which are also substrates of the mitochondrial import and assembly (MIA) pathway .

What protein interaction networks involve hTim8a in mitochondria?

Protein interaction studies have revealed that hTim8a is part of a complex network involving:

  • Complex IV assembly factors: COX17, COA4, COA6, COA7, and COX6B1

  • MICOS/MIB complex components that maintain mitochondrial architecture

  • Mitochondrial translocase subunits (TIMM and TOMM proteins)

  • MIA pathway substrates

Crosslinked immunoprecipitation experiments have shown that Mia40 interacts with hTim8a, hTim8b, and hTim13, but not with other small TIM family members like hTim10a, hTim10b, and hTim9 . This suggests that the interaction between hTim8a, hTim8b, hTim13, and Mia40 may have functional significance in the assembly of respiratory chain complexes.

How can oxidative stress resulting from TIMM8A dysfunction be measured and mitigated?

Oxidative stress in TIMM8A-deficient models can be assessed through:

  • Measurement of reactive oxygen species using fluorescent probes (DCFDA, MitoSOX)

  • Analysis of lipid peroxidation markers

  • Quantification of protein oxidation (carbonylation)

  • Assessment of antioxidant enzyme activities

  • Measurement of glutathione levels and redox state

Research has demonstrated that cells lacking hTim8a show increased sensitivity to apoptotic stimuli, which can be rescued by antioxidant treatment. Specifically, Vitamin E treatment alleviates oxidative stress in these cells, rescuing them from apoptotic vulnerability . This finding suggests that early intervention with antioxidants could represent a treatment strategy for mitochondrial neuropathologies like MTS.

What are the most suitable cellular models for studying TIMM8A function?

Several cell models have proven valuable for TIMM8A research:

  • SH-SY5Y neuroblastoma cells: These serve as an in vitro model of neuronal function and are particularly useful given the neurological phenotype of MTS

  • HEK293 cells: Used for comparative studies to understand cell-specific functions of hTim8a

  • CRISPR/Cas9-edited cell lines: Gene editing has been used to create knockout or mutant cell lines for both TIMM8A and TIMM8B

Comparative studies using these models have revealed critical insights about the cell-specific roles of small TIM proteins. For example, loss of hTim8a has more severe consequences in neuronal-like SH-SY5Y cells, with major impacts on cell viability, mitochondrial membrane potential, Complex IV activity, and oxidative stress .

How can researchers distinguish between the functions of hTim8a and hTim8b?

Distinguishing between hTim8a and hTim8b functions requires multiple approaches:

  • Comparative knockout studies in different cell types to reveal cell-specific dependencies

  • Rescue experiments where one paralog is expressed in cells lacking the other

  • Proteomic analysis to identify unique interaction partners

  • Structural studies of the respective heterohexameric complexes

  • Analysis of tissue-specific expression patterns

Research has shown that both proteins rely on hTim13 for heterohexamer formation but form independent complexes that function in distinct cellular contexts . The unique functions of hTim8a in neuronal cells explain why only TIMM8A mutations are associated with neurological disease.

What techniques are most effective for analyzing heterohexameric complexes formed by small TIM proteins?

The heterohexameric complexes formed by hTim8a and hTim8b with hTim13 can be analyzed using:

  • Size exclusion chromatography (SEC) to determine complex size and composition

  • Blue Native PAGE to visualize native protein complexes

  • Recombinant protein expression and in vitro complex reconstitution

  • siRNA knockdown studies to assess dependencies (e.g., knockdown of hTim13 decreases both hTim8a and hTim8b complex formation)

  • Crosslinking coupled with mass spectrometry to determine protein arrangement within complexes

These techniques have revealed that in mitochondria, both hTim8a and hTim8b assemble into ~140 kDa complexes, which is distinct from their heterohexameric assemblies observed in vitro .

What are potential therapeutic strategies for Mohr-Tranebjærg syndrome based on current TIMM8A research?

Current research suggests several potential therapeutic approaches for MTS:

  • Antioxidant therapy: Vitamin E treatment has been shown to rescue hTim8a-deficient cells from apoptotic vulnerability by alleviating oxidative stress

  • Targeting Complex IV assembly: Approaches to stabilize or enhance the assembly of Complex IV could potentially bypass the requirement for hTim8a

  • Gene therapy approaches: Restoration of functional TIMM8A expression in affected neuronal populations

  • Modulation of apoptotic pathways: Targeting the increased sensitivity to apoptosis observed in hTim8a-deficient cells

The finding that oxidative stress is a key driver of pathology in cells lacking hTim8a suggests that early intervention with antioxidants could be a promising treatment strategy for MTS .

How might understanding TIMM8A function contribute to broader knowledge of mitochondrial diseases?

Research on TIMM8A provides insights into several aspects of mitochondrial biology:

  • The specialized roles of small TIM chaperones in human mitochondria compared to yeast

  • Cell type-specific requirements for respiratory chain complex assembly

  • Links between respiratory chain defects, oxidative stress, and apoptotic sensitivity

  • The importance of proper copper distribution for mitochondrial function, as suggested by hTim8a's interaction with the copper chaperone COX17

The distinct roles of hTim8a in neuronal cells also highlight the specialized nature of neuronal mitochondria and their particular vulnerability to dysfunction, which is relevant to understanding numerous neurodegenerative disorders.

What are the most pressing unresolved questions in TIMM8A research?

Several important questions remain to be addressed:

  • What is the precise molecular mechanism by which hTim8a facilitates Complex IV assembly?

  • How do the structures of hTim8a-hTim13 and hTim8b-hTim13 heterohexamers differ, and how do these differences contribute to their specific functions?

  • Why are neuronal cells particularly vulnerable to hTim8a deficiency?

  • What is the developmental role of hTim8a, given its high expression in fetal brain?

  • Can antioxidant therapy effectively prevent or slow neurodegeneration in MTS patients?

Addressing these questions will require continued research using advanced techniques in structural biology, proteomics, and cellular neuroscience, as well as the development of improved animal models of MTS.

Product Science Overview

Structure and Function

TIMM8A is a mitochondrial intermembrane chaperone that forms a complex with another protein called TIMM13 . This complex, often referred to as the TIM8-TIM13 complex, is essential for the import and insertion of multi-pass transmembrane proteins into the mitochondrial inner membrane . The TIM8-TIM13 complex also facilitates the transfer of beta-barrel precursors from the TOM complex (Translocase of the Outer Membrane) to the SAM complex (Sorting and Assembly Machinery) of the outer membrane .

Genetic and Clinical Significance

Mutations in the TIMM8A gene are associated with several genetic disorders, including Mohr-Tranebjaerg syndrome (MTS), also known as Deafness-Dystonia Syndrome (DDS) . This X-linked recessive neurodegenerative disorder is characterized by progressive hearing loss, dystonia, and other neurological symptoms . Additionally, defects in the TIMM8A gene can cause Jensen syndrome, an X-linked disease marked by opticoacoustic nerve atrophy and muscle weakness .

Research and Applications

The recombinant form of TIMM8A is used in various research applications to study its role in mitochondrial function and its involvement in mitochondrial diseases . Understanding the mechanisms by which TIMM8A and its associated complexes operate can provide insights into the development of therapeutic strategies for mitochondrial disorders.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.